Public/private partnership expands access to comprehensive genomic profiling to improve patient care and advance drug discovery
At ESHG in Vienna, Illumina representatives engaged with an impressive group of geneticists and entrepreneurs
How artificial intelligence and automation are enabling precision medicine to become the standard of care
At ASCO 2022, an oncology panel discusses the benefits and practices of comprehensive genomic profiling
Illumina’s global program aims to inspire the next generation of genomic leaders
| Date | Publication | Title |
|---|---|---|
| Jun 17, 2022 | Biotech Dispatch | Illumina's Susan Tousi on genomics and changing healthcare |
| Jun 16, 2022 | Business Weekly | Illumina toasts Accelerator success in Cambridge |
| Jun 9, 2022 | Targeted Oncology | New Pan-Cancer CDx Added to the TruSight Oncology Test |
| Jun 5, 2022 | STAT | Illumina, maker of a key tool for drug discovery, to try making new drugs itself |
| May 26, 2022 | Channel News Asia | DNA of 100,000 Singaporeans to be sequenced, analysed to improve population health |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
